# Phenoxybenzamine Versus Doxazosin in PCC Patients

> **NCT01379898** · PHASE4 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 134 (actual)

## Conditions studied

- Pheochromocytoma

## Interventions

- **DRUG:** Phenoxybenzamine
- **DRUG:** Doxazosin

## Key facts

- **NCT ID:** NCT01379898
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379898, "Phenoxybenzamine Versus Doxazosin in PCC Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01379898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*